Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
F M Sullivan
Dr F M Sullivan, University of Dundee, Dundee, UK; email@example.com
2 × 2 factorial, randomised, placebo-controlled trial.
blinded (clinicians, patients, data collectors, and outcome assessors).*
17 hospitals in Scotland, UK.
551 patients ⩾16 years of age (mean age 44 y, 51% men) with unilateral facial nerve weakness of no identifiable cause who were referred by their primary care physician or the emergency department within 72 hours of onset of symptoms. Exclusion criteria included pregnancy, uncontrolled diabetes, peptic ulcer disease, herpes zoster, and multiple sclerosis. 54% of patients started treatment within 24 hours of onset of symptoms. Mean score on the 6-grade House–Brackmann scale was 3.6 (higher grade indicates worse facial paralysis).
prednisolone, 25 mg twice daily, plus placebo for acyclovir (n = 138); acyclovir, 400 mg 5 …
Source of funding: Health Technology Assessment Program of the National Institute for Health Research.